Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: August 2017

Christie Administration Announces $500,000 Grant Opportunity to Integrate Health Care for Military, Veterans and First Responders

Trenton, NJ, August 17, 2017 — The New Jersey Department of Health yesterday announced a $500,000 grant opportunity to support a pilot program to integrate primary care, behavioral health, palliative care, hospice and telehealth services for military persons, veterans and first responders.

This one-year grant opportunity is available to New Jersey hospitals, healthcare systems, federally qualified health centers, or state university providers of behavioral health services.

Military personnel, veterans and first responders often deal with primary care and behavioral health challenges. Offering the integration of healthcare across the continuum will help create a seamless system of care. Continue reading

Opinion: Assemblymen and Stevens President Urge ‘Restore Funding to Turbocharge NJ’s Research and Development’

Trenton, NJ, August 16, 2017Assemblyman Raj Mukherji (D-Hudson), Assemblyman Troy Singleton (D-Burlington) and Dr. Nariman Farvardin, president of Stevens Institute of Technology, write on innovation and Assembly No. 5123 in an op-ed published on August 15 in The Star-Ledger:

One need only to look at the top performers in the S&P 500 — Amazon, Apple, Google parent Alphabet and Facebook — to confirm an indisputable fact about our modern economy: Technological innovation is the key driver of economic growth.

Policymakers who ignore technology’s disruptive impact on markets, industries and jobs do so at their constituents’ peril. (Think Amazon’s impact on the retail industry.) Continue reading

Vendors Event: HINJ and Somerset County Business Partnership to Host 2017 Life Sciences Vendors Procurement Conference on November 2

New Brunswick, NJ, August 16, 2017 — The HealthCare Institute of New Jersey’s (HINJ) annual Life Sciences Vendors Procurement Conference is scheduled for Thursday, November 2 from 8:00 to 11:30 a.m. at Raritan Valley Community College, Route 28 and Lamington Road, North Branch, NJ.

The event — entitled “How to Do Business with Pharma and Medical Technology Companies” — will be co-sponsored by the Somerset County Business Partnership (SCBP) with support from Eli Lilly and Company and Allergan.

Senator Kip Bateman (R-Somerset) will be the special guest speaker at the event that aims to educate businesses, large and small, on trends on procurement and issues of importance to the industry. Continue reading

Life Sciences Talent Network Shaping Future Leaders in NJ’s Biotech Industry

Trenton, NJ, August 16, 2017Matt Alcalde, Director of Life Sciences Talent Network at BioNJ, writes:

Now in its second year, the Life Sciences Talent Advisory Board, managed by the Life Sciences Talent Network at BioNJ, has engaged over 100 employers from New Jersey’s robust health and life sciences industry.

These employers include pharmaceutical, biotechnology and medical device companies that are researching and developing new drugs and therapies to treat various diseases affecting patients worldwide as well as others who are supporting that work. Continue reading

U.S. Senate’s ‘Right to Try’ Bill Could Face Slower Action in House

Washington, DC, August 15, 2017Roll Call reports that a U.S. Senate-passed “right to try” bill that is intended to help dying patients access experimental drugs, which have yet to receive Food and Drug Administration (FDA), likely will face lengthier deliberations in the U.S. House of Representatives.

While the Senate fast-tracked the bill on August 3, the House will likely subject it to a hearing and markup before bringing it up to a vote, according to congressional aides and a lobbyist.

The bill would reduce some of the paperwork involved in getting access to experimental treatments, and would offer protections to the drug companies who choose to make drugs available outside of a clinical trial. Continue reading

After 2-Year Hiatus, 2.3 Percent Medical Device Tax Could Be Reinstated on January 1; Industry Launches Campaign

Washington, DC, August 15, 2017 — Bob Salsberg reports in The Washington Post that the industry that makes medical devices from artificial hips to miniature pumps for IV drips is looking for a fallback plan to permanently repeal a widely reviled sales tax that almost met its end in Republicans’ health care legislation.

The 2.3 percent medical device excise tax — one of several taxes and fees in the Affordable Care Act that pay for expanded insurance coverage — has been the subject of ferocious lobbying by manufacturers seeking its permanent death.

Yet for now it’s on track to be reinstated on Jan. 1 after a two-year hiatus, leaving industry leaders worried it will hurt employment and stifle development of innovative, even lifesaving products. Continue reading

STAT: FDA Puts New Restrictions on Hiring of Foreign Scientists, Documents Show

Washington, DC, August 14, 2017 — Erin Mershon reports on STAT that the Food and Drug Administration (FDA) is implementing a new hiring protocol that could make it significantly harder for foreign scientists to find jobs and research opportunities at the agency, according to interviews and newly obtained documents.

Mershon reports that the FDA recently began directing hiring managers not to extend any employment offers — including for fellowship and contractor positions — to any individual who has not lived in the U.S. for at least three of the five previous years, according to briefing materials shared with STAT that have been presented to some agency employees. Continue reading

NJ Economic Development Authority Board Takes Action to Drive Pharmaceutical Manufacturing Growth

Trenton, NJ, August 13, 2017 — The Board of the New Jersey Economic Development Authority (EDA) took action on August 8 that will help advance one of the key legislative objectives of the Economic Opportunity Act (EOA) — driving growth in targeted industries.

Potential investment in the manufacturing sector was highlighted at EDA Board meeting, as three manufacturers of pharmaceutical products were approved for Grow New Jersey (Grow NJ) tax credits to either locate or expand in New Jersey.

Grow NJ is the main job creation and retention program administered under the EOA. Continue reading

New Jersey Celebrates National Health Center Week 2017 August 13-19

Trenton, NJ, August 12, 2017 — The New Jersey Department of Health will celebrate National Health Center Week 2017, which is August 13 to 14, by showcasing the comprehensive health care that is provided at more than 100 Federally Qualified Health Centers across the state with about 70 events.

Events will include free medical and dental screenings, information sessions about cancer prevention, improving birth outcomes, diabetes, nutrition and fitness, as well as back-to-school giveaways, food and entertainment for families.

Health Commissioner Cathleen D. Bennett will speak at the kickoff event on Monday, August 14 at the Metropolitan Family Health Network in Jersey City from 11 a.m. to 2 p.m. Continue reading

Vendors Event: HINJ and Somerset County Business Partnership to Host 2017 Life Sciences Vendors Procurement Conference on November 2

New Brunswick, NJ, August 11, 2017 — The HealthCare Institute of New Jersey’s (HINJ) annual Life Sciences Vendors Procurement Conference is scheduled for Thursday, November 2 from 8:00 to 11:30 a.m. at Raritan Valley Community College, Route 28 and Lamington Road, North Branch, NJ.

The event — entitled “How to Do Business with Pharma and Medical Technology Companies” — will be co-sponsored by the Somerset County Business Partnership (SCBP) with support from Eli Lilly and Company and Allergan.

Senator Kip Bateman (R-Somerset) will be the special guest speaker at the event that aims to educate businesses, large and small, on trends on procurement and issues of importance to the industry. Continue reading